BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Bumetanide

A sulfamyl diuretic.

299+ PubMed studies analyzed · 37 RCTs · Evidence Score: 47.8

Research Domains

Bumetanide has been studied across 20 research domains including 🫘 Kidney, ❤️ Cardiovascular, 🧠 Focus & Attention, 🫁 Liver & Detox, 🧠 Memory. The primary research focus is 🫘 Kidney with 15% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bumetanide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Furosemide
16 shared targets
Chlorthalidone
13 shared targets
Metolazone
14 shared targets
stx64
14 shared targets
benzolamide
12 shared targets
Indapamide
13 shared targets
Zonisamide
12 shared targets
24
10 shared targets
trichlormethiazide
10 shared targets
Sulfanilamide
12 shared targets
Loading evidence profile...

This evidence profile for Bumetanide is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.